270 related articles for article (PubMed ID: 31333464)
21. Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells.
Noureddine N; Hartling I; Wawrzyniak P; Srikanthan P; Lou PH; Lucchinetti E; Krämer SD; Rogler G; Zaugg M; Hersberger M
Am J Clin Nutr; 2022 Sep; 116(3):786-797. PubMed ID: 35849016
[TBL] [Abstract][Full Text] [Related]
22. Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis.
Yamada H; Saegusa J; Sendo S; Ueda Y; Okano T; Shinohara M; Morinobu A
Sci Rep; 2021 Aug; 11(1):17312. PubMed ID: 34453072
[TBL] [Abstract][Full Text] [Related]
23. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice.
Klein CP; Sperotto ND; Maciel IS; Leite CE; Souza AH; Campos MM
Neuropharmacology; 2014 Nov; 86():57-66. PubMed ID: 24929111
[TBL] [Abstract][Full Text] [Related]
24. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus.
Barden A; Shinde S; Phillips M; Beilin L; Mas E; Hodgson JM; Puddey I; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2018 Jun; 133():29-34. PubMed ID: 29789130
[TBL] [Abstract][Full Text] [Related]
25. Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain.
Shim HS; Bae C; Wang J; Lee KH; Hankerd KM; Kim HK; Chung JM; La JH
Mol Pain; 2019; 15():1744806919840098. PubMed ID: 30857460
[TBL] [Abstract][Full Text] [Related]
26. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
Toyama S; Shimoyama N; Shimoyama M
Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
[TBL] [Abstract][Full Text] [Related]
27. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain.
Leuti A; Fava M; Pellegrini N; Maccarrone M
Front Pharmacol; 2021; 12():717993. PubMed ID: 34456731
[TBL] [Abstract][Full Text] [Related]
28. Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.
Ye Y; Scheff NN; Bernabé D; Salvo E; Ono K; Liu C; Veeramachaneni R; Viet CT; Viet DT; Dolan JC; Schmidt BL
Neuropharmacology; 2018 Sep; 139():182-193. PubMed ID: 30009833
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
30. Magnolin Inhibits Paclitaxel-Induced Cold Allodynia and ERK1/2 Activation in Mice.
Kim N; Chung G; Son SR; Park JH; Lee YH; Park KT; Cho IH; Jang DS; Kim SK
Plants (Basel); 2023 Jun; 12(12):. PubMed ID: 37375908
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.
Makker PG; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G
PLoS One; 2017; 12(1):e0170814. PubMed ID: 28125674
[TBL] [Abstract][Full Text] [Related]
32. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN; Gotlinger K; Hong S; Arita M
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
[TBL] [Abstract][Full Text] [Related]
33. Prevention of Chronic Post-Thoracotomy Pain in Rats By Intrathecal Resolvin D1 and D2: Effectiveness of Perioperative and Delayed Drug Delivery.
Wang JC; Strichartz GR
J Pain; 2017 May; 18(5):535-545. PubMed ID: 28063958
[TBL] [Abstract][Full Text] [Related]
34. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
[TBL] [Abstract][Full Text] [Related]
35. Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain.
Antoniazzi CTD; Nassini R; Rigo FK; Milioli AM; Bellinaso F; Camponogara C; Silva CR; de Almeida AS; Rossato MF; De Logu F; Oliveira SM; Cunha TM; Geppetti P; Ferreira J; Trevisan G
Int J Cancer; 2019 Jan; 144(2):355-365. PubMed ID: 30289972
[TBL] [Abstract][Full Text] [Related]
36. Resolvin D5 (RvD5) Reduces Renal Damage Caused by LPS Endotoxemia in Female Mice.
Cardoso RDR; Chambo SD; Zaninelli TH; Bianchini BHS; Silva MDVD; Bertozzi MM; Saraiva-Santos T; Franciosi A; Martelossi-Cebinelli G; Garcia-Miguel PE; Borghi SM; Casagrande R; Verri WA
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615318
[TBL] [Abstract][Full Text] [Related]
37. Efficient biotransformation of docosahexaenoic acid-rich oils into the lipid mediator resolvin D5 by cells expressing 15S-lipoxygenase using a bioreactor.
Lee J; Park HA; Shin KC; Park JB; Oh DK
Bioresour Technol; 2023 Nov; 388():129750. PubMed ID: 37717704
[TBL] [Abstract][Full Text] [Related]
38. TRPA1 involvement in analgesia induced by Tabernaemontana catharinensis ethyl acetate fraction in mice.
Brum EDS; Becker G; Fialho MFP; Casoti R; Trevisan G; Oliveira SM
Phytomedicine; 2019 Feb; 54():248-258. PubMed ID: 30668375
[TBL] [Abstract][Full Text] [Related]
39. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
[TBL] [Abstract][Full Text] [Related]
40. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR
FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
